• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 宿主嗜性:主要细胞因子的计算分析。

SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.

机构信息

Laboratorio de Virología Molecular, Centro de Microbiología y Biología Celular, Instituto Venezolano de Investigaciones Científicas, Caracas, Venezuela.

Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.

出版信息

Virus Res. 2020 Nov;289:198154. doi: 10.1016/j.virusres.2020.198154. Epub 2020 Sep 9.

DOI:10.1016/j.virusres.2020.198154
PMID:32918944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7480320/
Abstract

Recent reports have shown that small and big felines could be infected by SARS-CoV-2, while other animals, like swines and mice, are apparently not susceptible to this infection. These findings raise the question of the role of cell factors associated with early stages of the viral infection in host selectivity. The cellular receptor for SARS-CoV-2 is the Angiotensin Converting Enzyme (ACE2). Transmembrane protease serine 2 (TMPRSS2) has been shown to prime the viral spike for its interaction with its receptor. GRP78 has also been proposed as a possible co-receptor. In this study, we used several bioinformatics approaches to bring clues in the interaction of ACE2, TMPRSS2, and GRP78 with SARS-CoV-2. We selected several mammalian hosts that could play a key role in viral spread by acting as secondary hosts (cats, dogs, pigs, mice, and ferrets) and evaluated their predicted permissiveness by in silico analysis. Results showed that ionic pairs (salt bridges, N-O pair, and long-range interactions) produced between ACE2 and the viral spike has an essential function in the host interaction. On the other hand, TMPRSS2 and GRP78 are proteins with high homology in all the evaluated hosts. Thus, these proteins do not seem to play a role in host selectivity, suggesting that other factors may play a role in the non-permissivity in some of these hosts. These proteins represent however interesting cell targets that could be explored in order to control the virus replication in humans and in the intermediary hosts.

摘要

最近的报告表明,小型和大型猫科动物可能会感染 SARS-CoV-2,而其他动物,如猪和老鼠,显然不易感染这种病毒。这些发现提出了一个问题,即与病毒感染早期阶段相关的细胞因子在宿主选择性中的作用。SARS-CoV-2 的细胞受体是血管紧张素转换酶(ACE2)。已表明跨膜丝氨酸蛋白酶 2(TMPRSS2)可使病毒刺突蛋白为与其受体相互作用做好准备。GRP78 也被提议为可能的共受体。在这项研究中,我们使用了几种生物信息学方法来揭示 ACE2、TMPRSS2 和 GRP78 与 SARS-CoV-2 的相互作用。我们选择了几种可能通过充当次要宿主(猫、狗、猪、老鼠和雪貂)在病毒传播中发挥关键作用的哺乳动物宿主,并通过计算机分析评估它们的预测易感性。结果表明,ACE2 和病毒刺突之间产生的离子对(盐桥、N-O 对和远程相互作用)在宿主相互作用中具有重要功能。另一方面,TMPRSS2 和 GRP78 是所有评估宿主中具有高度同源性的蛋白质。因此,这些蛋白质似乎在宿主选择性中不起作用,这表明其他因素可能在其中一些宿主的非许可性中起作用。然而,这些蛋白质代表了有趣的细胞靶标,可以探索它们以控制人类和中间宿主中的病毒复制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/c0562a23e3fd/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/b0691fbf231a/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/4936d296a65e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/e3a22b341c37/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/0c4ea23d38fc/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/42cad9536a6a/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/5e6f715db371/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/6ed6a05c718f/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/c0562a23e3fd/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/b0691fbf231a/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/4936d296a65e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/e3a22b341c37/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/0c4ea23d38fc/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/42cad9536a6a/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/5e6f715db371/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/6ed6a05c718f/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5379/7480320/c0562a23e3fd/gr7_lrg.jpg

相似文献

1
SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.SARS-CoV-2 宿主嗜性:主要细胞因子的计算分析。
Virus Res. 2020 Nov;289:198154. doi: 10.1016/j.virusres.2020.198154. Epub 2020 Sep 9.
2
Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals.高度保守的 ACE2 结合区域作为人类和哺乳动物之间 SARS-CoV-2 的受体。
Vet Q. 2020 Dec;40(1):243-249. doi: 10.1080/01652176.2020.1823522.
3
Structural and functional modelling of SARS-CoV-2 entry in animal models.SARS-CoV-2 入侵动物模型的结构和功能建模。
Sci Rep. 2020 Sep 28;10(1):15917. doi: 10.1038/s41598-020-72528-z.
4
In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.计算机模拟研究阿奇霉素、氯喹和羟氯喹及其对 SARS-CoV-2 感染的潜在作用机制。
Int J Antimicrob Agents. 2020 Sep;56(3):106119. doi: 10.1016/j.ijantimicag.2020.106119. Epub 2020 Jul 30.
5
Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.严重急性呼吸综合征冠状病毒 2 刺突蛋白与人、宠物、农场动物和潜在中间宿主 ACE2 受体结合的比较。
J Virol. 2020 Jul 16;94(15). doi: 10.1128/JVI.00831-20.
6
Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.SARS-COV-2 刺突糖蛋白的优化假型条件。
J Virol. 2020 Oct 14;94(21). doi: 10.1128/JVI.01062-20.
7
Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19.阿比多尔(盐酸奥司他韦)骨架变形以寻求多靶点治疗,阻止 SARS-CoV-2 与 ACE2 和 COVID-19 中涉及的其他蛋白酶的相互作用。
Virus Res. 2020 Nov;289:198146. doi: 10.1016/j.virusres.2020.198146. Epub 2020 Aug 29.
8
Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对动物血管紧张素转换酶2受体的广泛及差异性利用
J Virol. 2020 Aug 31;94(18). doi: 10.1128/JVI.00940-20.
9
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
10
Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.冠状病毒刺突蛋白和宿主 ACE2 受体的组成和分化预测了 SARS-CoV-2 的潜在中间宿主。
J Med Virol. 2020 Jun;92(6):595-601. doi: 10.1002/jmv.25726. Epub 2020 Mar 11.

引用本文的文献

1
Identification of a druggable site on GRP78 at the GRP78-SARS-CoV-2 interface and virtual screening of compounds to disrupt that interface.鉴定 GRP78-SARS-CoV-2 界面上 GRP78 的一个可成药位点,并对破坏该界面的化合物进行虚拟筛选。
J Comput Aided Mol Des. 2024 Jan 24;38(1):6. doi: 10.1007/s10822-023-00546-w.
2
Distinct evolutionary trajectories of SARS-CoV-2-interacting proteins in bats and primates identify important host determinants of COVID-19.SARS-CoV-2 与蝙蝠和灵长类动物相互作用的蛋白质具有不同的进化轨迹,这表明 COVID-19 的发生与宿主有重要关系。
Proc Natl Acad Sci U S A. 2022 Aug 30;119(35):e2206610119. doi: 10.1073/pnas.2206610119. Epub 2022 Aug 10.
3

本文引用的文献

1
Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative Against SARS-CoV2: An In Silico Analysis.A 类 G 蛋白偶联受体拮抗剂法莫替丁作为对抗 SARS-CoV-2 的治疗新选择:一项计算机模拟分析。
Biomolecules. 2020 Jun 24;10(6):954. doi: 10.3390/biom10060954.
2
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在人血管紧张素转换酶2(hACE2)转基因小鼠中的致病性。
Nature. 2020 Jul;583(7818):830-833. doi: 10.1038/s41586-020-2312-y. Epub 2020 May 7.
3
A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID-19 and response to treatment.
系统分析表明,热力学生理和药理学基础驱动着 COVID-19 及其对治疗的反应。
Pharmacol Res Perspect. 2022 Feb;10(1):e00922. doi: 10.1002/prp2.922.
4
Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: An In Silico Analysis.奥密克戎SARS-CoV-2变体刺突蛋白对人ACE2受体的亲和力增加:一项计算机模拟分析。
Pathogens. 2021 Dec 31;11(1):45. doi: 10.3390/pathogens11010045.
5
Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines.mRNA、腺病毒载体和灌注蛋白 COVID-19 疫苗的功效。
Biomed Pharmacother. 2022 Feb;146:112527. doi: 10.1016/j.biopha.2021.112527. Epub 2021 Dec 10.
6
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review.微小 RNA 在解决新冠病毒感染到治疗的谜题中的作用:一篇迷你综述。
Virus Res. 2022 Jan 15;308:198631. doi: 10.1016/j.virusres.2021.198631. Epub 2021 Nov 14.
7
SARS-CoV-2 S glycoprotein binding to multiple host receptors enables cell entry and infection.SARS-CoV-2 的 S 糖蛋白与多种宿主受体结合,使病毒能够进入细胞并感染细胞。
Glycoconj J. 2021 Oct;38(5):611-623. doi: 10.1007/s10719-021-10021-z. Epub 2021 Sep 20.
8
In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin.计算机模拟比较 SARS-CoV-2 刺突蛋白与 ACE2 的结合亲和力在不同物种间的差异及其对病毒起源的影响。
Sci Rep. 2021 Jun 24;11(1):13063. doi: 10.1038/s41598-021-92388-5.
9
Structural analysis of COVID-19 spike protein in recognizing the ACE2 receptor of different mammalian species and its susceptibility to viral infection.新冠病毒刺突蛋白识别不同哺乳动物物种血管紧张素转换酶2(ACE2)受体的结构分析及其对病毒感染的易感性
3 Biotech. 2021 Feb;11(2):109. doi: 10.1007/s13205-020-02599-2. Epub 2021 Feb 1.
SARS-CoV-2 综述及正在进行的临床试验。
Int J Mol Sci. 2020 Apr 10;21(7):2657. doi: 10.3390/ijms21072657.
4
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2.利用人血管紧张素转化酶 2 进入 SARS-CoV-2 的结构和功能基础
Cell. 2020 May 14;181(4):894-904.e9. doi: 10.1016/j.cell.2020.03.045. Epub 2020 Apr 9.
5
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.雪貂、猫、狗和其他驯养动物对 SARS-CoV-2 的易感性。
Science. 2020 May 29;368(6494):1016-1020. doi: 10.1126/science.abb7015. Epub 2020 Apr 8.
6
SARS-CoV-2 Vaccines: Status Report.SARS-CoV-2 疫苗:现状报告。
Immunity. 2020 Apr 14;52(4):583-589. doi: 10.1016/j.immuni.2020.03.007. Epub 2020 Apr 6.
7
Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).新型冠状病毒病 2019(COVID-19)的流行病学、诊断、治疗和疫苗的现状。
J Microbiol Biotechnol. 2020 Mar 28;30(3):313-324. doi: 10.4014/jmb.2003.03011.
8
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases.新型冠状病毒肺炎及相关人类冠状病毒疾病治疗药物和疫苗的研发
ACS Cent Sci. 2020 Mar 25;6(3):315-331. doi: 10.1021/acscentsci.0c00272. Epub 2020 Mar 12.
9
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.SARS-CoV-2 刺突受体结合域与 ACE2 受体复合物的结构。
Nature. 2020 May;581(7807):215-220. doi: 10.1038/s41586-020-2180-5. Epub 2020 Mar 30.
10
Structural basis of receptor recognition by SARS-CoV-2.SARS-CoV-2 受体识别的结构基础。
Nature. 2020 May;581(7807):221-224. doi: 10.1038/s41586-020-2179-y. Epub 2020 Mar 30.